COVID-19 Pandemic: Utilization and Aftermath of Telehealth Services
Expect a discussion focusing on the top legal and regulatory issues affecting the delivery and reimbursement of telehealth services during the COVID-19 pandemic and how legislatures and government agencies at federal and state levels are responding in the aftermath to implement permanent changes and enforce fraudulent activities.
The session will provide valuable insights for startups and existing telemedicine practices seeking to understand strategic planning to optimize market success and maintain a compliant multi-state practice.
Topics and Learnings:
1. Use of telehealth services in Medicare and Medicaid programs
2. Flexibilities applied during the pandemic to ensure access to safer health care
3. Key changes and pending legislation impacting telehealth and technology-based services
4. How government enforcement agencies are assessing and acting on vulnerabilities to fraud and abuse
5. How to evaluate corporate structure and business arrangements for fraud and abuse compliance
Speakers:
- CAROLYN YOCOM, Director of Health Care Team, US Government Accountability Office (GAO)
- CHARLES C. DUNHAM, IV, Shareholder, Greenberg Traurig, LLP
Speakers
- Micaela Seemann Monteiro, MD, Chief Medical Officer for Digital Transformation, CUF, Portugal
- Dipak Kalra, President, The European Institute for Innovation Through Health Data, Belgium
- Saara Malkamaki, Specialist, Sitra/TEHDAS, Health Data 2030, Sitra, Finland
- Stephan Schug, President, German eHealth Association and Chief Digital Strategist, Iqmed, Germany
|
